首页 > 最新文献

MUSICAL QUARTERLY最新文献

英文 中文
On the Vicissitudes of Handel’s Operatic Time: A Meditation 论韩德尔歌剧时代的变迁:一种沉思
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-11-02 DOI: 10.1093/MUSQTL/GDAB017
Ellen Rosand
{"title":"On the Vicissitudes of Handel’s Operatic Time: A Meditation","authors":"Ellen Rosand","doi":"10.1093/MUSQTL/GDAB017","DOIUrl":"https://doi.org/10.1093/MUSQTL/GDAB017","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42508179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of: "Co-occurrence networks reveal the central role of temperature in structuring the plankton community of the Thau Lagoon" 综述:“共生网络揭示了温度在陶湖浮游生物群落结构中的核心作用”
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-09-27 DOI: 10.32388/w6mq1y
Xiang Zhang
{"title":"Review of: \"Co-occurrence networks reveal the central role of temperature in structuring the plankton community of the Thau Lagoon\"","authors":"Xiang Zhang","doi":"10.32388/w6mq1y","DOIUrl":"https://doi.org/10.32388/w6mq1y","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45313680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of: "The structural basis of odorant recognition in insect olfactory receptors" 综述:“昆虫嗅觉受体气味识别的结构基础”
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-08-22 DOI: 10.32388/72z1mq
A. Bogdanov
{"title":"Review of: \"The structural basis of odorant recognition in insect olfactory receptors\"","authors":"A. Bogdanov","doi":"10.32388/72z1mq","DOIUrl":"https://doi.org/10.32388/72z1mq","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44744178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of: "Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia" 综述:“室上性心动过速导管消融术治疗肺动脉高压患者的长期预后”
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-08-17 DOI: 10.32388/z5u4mq
B. Brembilla-Perrot
{"title":"Review of: \"Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia\"","authors":"B. Brembilla-Perrot","doi":"10.32388/z5u4mq","DOIUrl":"https://doi.org/10.32388/z5u4mq","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48326378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Speculative Hermeneutics for Music Analysis and Interpretation 音乐分析与诠释的思辨诠释学
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-08-02 DOI: 10.1093/musqtl/gdab006
R. Hatten
{"title":"A Speculative Hermeneutics for Music Analysis and Interpretation","authors":"R. Hatten","doi":"10.1093/musqtl/gdab006","DOIUrl":"https://doi.org/10.1093/musqtl/gdab006","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43523650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expected survival of cancer patients and myeloma undergoing bisphosphonates or denosumab. Potential impact on diagnosis and management of Osteonecrosis of Jaws (ONJ) 癌症和骨髓瘤患者接受双膦酸盐或替诺沙单抗治疗的预期存活率。对颌骨骨坏死(ONJ)诊断和治疗的潜在影响
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-04-11 DOI: 10.32388/MQ2IYG
V. Fusco, M. Cabras, A. Gambino, M. Di Maio, R. Freilone, M. Tampellini, I. Romaniello, M. R. Alvaro, G. Numico, M. Rossi, C. Ortega, M. Tucci, D. Ottaviani, L. Buffoni, G. Scagliotti, G. Vellani, P. Varese, M. Franchini, C. Galassi
Survival of cancer and myeloma patients after diagnosis of bone lesions is largely variable. Appropriate medical therapy together with antiresorptive treatment (bisphosphonates or denosumab) can obtain prolonged survival with adequate quality of life. Osteonecrosis of Jaws (ONJ) is not rare in patients with bone metastatic cancer and myeloma patients, occurring mostly after prolonged antiresorptive treatment. Expected survival can influence the choice of antiresorptive treatment, the perception of ONJ risk, and even the ONJ management. We reviewed survival data after start of antiresorptive treatment of 509 ONJ patients registered in a cancer network database (Rete Oncologica Piemonte-Valle d’Aosta, North-Western Italy). Main characteristics: 196 males, 313 females; median age: 68 (39-89) years. Underlying disease: breast cancer: 42.9%; myeloma: 25.3%; prostate cancer: 17.2%; lung cancer: 6.7%; renal cancer: 2.5%; other cancer types: 4.3%. Main antiresorptive treatment: zoledronic acid: 79.4%; denosumab: 5.3%; other drugs/sequences: 15.3%.  Actuarial median survival (range) after the start of antiresorptive treatment was 66.0 (95% CI 57-77) months for breast cancer patients, 77.3 (95% CI 61.9-86.8) months for myeloma patients, 47.3. (95% CI 37.8-51.9) months for prostate cancer patients, 29.4 (95% CI 20.4-40.1) months for lung cancer patients, 39.4 (95% CI 20-107.3) months for renal cancer patients, 82.4 (95% CI 51.9-150.9) months for other cancer patients.  Two-, three- and four-year actuarial survival rates were respectively 91.7%%, 80.2%, 67.4% for breast cancer patients, 91.4%, 83.7%, 68.9% for myeloma patients, 78.4%, 61.2%, 41.9% for prostate cancer patients; 55.8%, 32.3%, 23.5% for lung cancer patients; 61.5%, 53.8%, 46.1% for renal cancer patients; 81.8%, 77.3%, 68.1% for others cancer types.  Our data support careful evaluation of short and long-term actuarial ONJ risk (versus short-term absolute risk) in the choice of antiresorptive treatment duration for bone metastatic cancer and myeloma patients. Furthermore, exclusion of jawbone surgery due to expected short survival in most of ONJ patients seems not warranted.
癌症和骨髓瘤患者在诊断为骨病变后的生存率在很大程度上是可变的。适当的药物治疗加上抗再吸收治疗(双膦酸盐或狄诺沙单抗)可以延长生存期,并提供足够的生活质量。颌骨骨坏死(ONJ)在骨转移性癌症和骨髓瘤患者中并不罕见,主要发生在长期抗再吸收治疗后。预期生存期可以影响抗再吸收治疗的选择、对ONJ风险的感知,甚至ONJ的管理。我们回顾了在癌症网络数据库(Rete Oncologica Piemonte-Valle d‘Aosta,意大利西北部)中注册的509名ONJ患者开始抗再吸收治疗后的生存数据。主要特征:男性196人,女性313人;中位年龄:68岁(39-89岁)。基础疾病:乳腺癌症:42.9%;骨髓瘤:25.3%;前列腺癌症:17.2%;癌症6.7%;癌症:2.5%;其他癌症类型:4.3%。主要抗再吸收治疗:唑来膦酸:79.4%;狄诺沙单抗:5.3%;其他药物/序列:15.3%。开始抗再吸收治疗后,癌症患者的实际中位生存期(范围)为66.0个月(95%CI 57-77),骨髓瘤患者为77.3个月(95%CI 61.9-86.8),47.3个月。前列腺癌症患者为(95%CI 37.8-51.9)个月,癌症患者为29.4(95%CI 20.4-4.0.1)个月;癌症患者为39.4(95%CI20-107.3)个月。癌症患者的2年、3年和4年精算生存率分别为91.7%、80.2%、67.4%,骨髓瘤患者为91.4%、83.7%、68.9%,癌症前列腺患者为78.4%、61.2%、41.9%;癌症患者分别为55.8%、32.3%、23.5%;癌症患者分别为61.5%、53.8%、46.1%;其他癌症类型分别为81.8%、77.3%、68.1%。我们的数据支持在选择骨转移性癌症和骨髓瘤患者的抗再吸收治疗持续时间时仔细评估短期和长期精算ONJ风险(相对于短期绝对风险)。此外,由于大多数ONJ患者的预期生存期较短,因此排除颚骨手术似乎没有必要。
{"title":"Expected survival of cancer patients and myeloma undergoing bisphosphonates or denosumab. Potential impact on diagnosis and management of Osteonecrosis of Jaws (ONJ)","authors":"V. Fusco, M. Cabras, A. Gambino, M. Di Maio, R. Freilone, M. Tampellini, I. Romaniello, M. R. Alvaro, G. Numico, M. Rossi, C. Ortega, M. Tucci, D. Ottaviani, L. Buffoni, G. Scagliotti, G. Vellani, P. Varese, M. Franchini, C. Galassi","doi":"10.32388/MQ2IYG","DOIUrl":"https://doi.org/10.32388/MQ2IYG","url":null,"abstract":"Survival of cancer and myeloma patients after diagnosis of bone lesions is largely variable. Appropriate medical therapy together with antiresorptive treatment (bisphosphonates or denosumab) can obtain prolonged survival with adequate quality of life. Osteonecrosis of Jaws (ONJ) is not rare in patients with bone metastatic cancer and myeloma patients, occurring mostly after prolonged antiresorptive treatment. Expected survival can influence the choice of antiresorptive treatment, the perception of ONJ risk, and even the ONJ management. We reviewed survival data after start of antiresorptive treatment of 509 ONJ patients registered in a cancer network database (Rete Oncologica Piemonte-Valle d’Aosta, North-Western Italy). Main characteristics: 196 males, 313 females; median age: 68 (39-89) years. Underlying disease: breast cancer: 42.9%; myeloma: 25.3%; prostate cancer: 17.2%; lung cancer: 6.7%; renal cancer: 2.5%; other cancer types: 4.3%. Main antiresorptive treatment: zoledronic acid: 79.4%; denosumab: 5.3%; other drugs/sequences: 15.3%.  Actuarial median survival (range) after the start of antiresorptive treatment was 66.0 (95% CI 57-77) months for breast cancer patients, 77.3 (95% CI 61.9-86.8) months for myeloma patients, 47.3. (95% CI 37.8-51.9) months for prostate cancer patients, 29.4 (95% CI 20.4-40.1) months for lung cancer patients, 39.4 (95% CI 20-107.3) months for renal cancer patients, 82.4 (95% CI 51.9-150.9) months for other cancer patients.  Two-, three- and four-year actuarial survival rates were respectively 91.7%%, 80.2%, 67.4% for breast cancer patients, 91.4%, 83.7%, 68.9% for myeloma patients, 78.4%, 61.2%, 41.9% for prostate cancer patients; 55.8%, 32.3%, 23.5% for lung cancer patients; 61.5%, 53.8%, 46.1% for renal cancer patients; 81.8%, 77.3%, 68.1% for others cancer types.  Our data support careful evaluation of short and long-term actuarial ONJ risk (versus short-term absolute risk) in the choice of antiresorptive treatment duration for bone metastatic cancer and myeloma patients. Furthermore, exclusion of jawbone surgery due to expected short survival in most of ONJ patients seems not warranted.","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48231646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Benign American Exceptionalism of Copland’s Fanfare for the Common Man 科普兰对普通人狂热的善意美国例外
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-03-15 DOI: 10.1093/MUSQTL/GDAA014
E. Ansari
{"title":"The Benign American Exceptionalism of Copland’s Fanfare for the Common Man","authors":"E. Ansari","doi":"10.1093/MUSQTL/GDAA014","DOIUrl":"https://doi.org/10.1093/MUSQTL/GDAA014","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":"103 1","pages":"246-280"},"PeriodicalIF":0.1,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/MUSQTL/GDAA014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47527287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rutland Boughton’s The Immortal Hour, the Celtic Twilight, and the Great War 拉特兰·博顿的《不朽的时刻》《凯尔特的黄昏》和《大战
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-03-15 DOI: 10.1093/MUSQTL/GDAA013
Matthew Buchan
{"title":"Rutland Boughton’s The Immortal Hour, the Celtic Twilight, and the Great War","authors":"Matthew Buchan","doi":"10.1093/MUSQTL/GDAA013","DOIUrl":"https://doi.org/10.1093/MUSQTL/GDAA013","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":"103 1","pages":"311-345"},"PeriodicalIF":0.1,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/MUSQTL/GDAA013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46693557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resisting Oblivion: Past Performances and Performers 抵制遗忘:过去的表演和表演者
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-03-15 DOI: 10.1093/MUSQTL/GDAB007
L. Botstein
{"title":"Resisting Oblivion: Past Performances and Performers","authors":"L. Botstein","doi":"10.1093/MUSQTL/GDAB007","DOIUrl":"https://doi.org/10.1093/MUSQTL/GDAB007","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":"103 1","pages":"237-245"},"PeriodicalIF":0.1,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/MUSQTL/GDAB007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42077540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Furious Trilogy: Arcadian Heroes on the Venetian Stage 《激情三部曲:威尼斯舞台上的阿卡迪亚英雄
IF 0.1 3区 艺术学 Q2 Arts and Humanities Pub Date : 2021-03-15 DOI: 10.1093/MUSQTL/GDAB001
Karen T. Raizen
{"title":"A Furious Trilogy: Arcadian Heroes on the Venetian Stage","authors":"Karen T. Raizen","doi":"10.1093/MUSQTL/GDAB001","DOIUrl":"https://doi.org/10.1093/MUSQTL/GDAB001","url":null,"abstract":"","PeriodicalId":45285,"journal":{"name":"MUSICAL QUARTERLY","volume":"103 1","pages":"346-393"},"PeriodicalIF":0.1,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/MUSQTL/GDAB001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46288048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"艺术学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
MUSICAL QUARTERLY
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1